Pic of RSV Shot for Adults

News

RSV, Age Recommendation

GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59

GSK GSK and Pfizer PFE announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the expanded use of their respiratory syncytial virus (RSV) vaccines.

The Associated Press on MSN · 3d

Experts make new recommendations on RSV and meningitis vaccines, but it’s unclear what happens next

ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis. The Advisory Committee on Immunization Practices also voted to recommend a shot to protect travelers from a mosquito-borne illness called chikungunya.

U.S. News & World Report · 3d

US CDC Advisers Recommend Lowering the Age for RSV Shots to 50-59 Years

The 15-member panel voted 14-to-0 to recommend that at-risk adults ages 50 to 59 receive a single dose of RSV vaccine. One of the panel members abstained from voting. The CDC currently recommends ...

MedPage Today on MSN4d

ACIP Endorses RSV Vaccine for At-Risk Adults 50 and Up

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...

New Atlas5d

Over 60s get long-term protection against RSV from single shot

A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older adults long-term protection against the infection, even if efficacy ...

Yahoo Finance3d

ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease

NEW YORK, April 16, 2025--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices ...

Medical Xpress13d

Older adults have low knowledge of RSV disease and vaccine eligibility

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, according to a study published online April 1 in JAMA Network Open.

U.S. News & World Report2d

Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya

The new recommendations include: Adults aged 50 to 59 with certain health problems, like heart disease, diabetes or chronic obstructive pulmonary disorder should be able to get the RSV shot.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results